|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| ($2,586, $3,165 and $3,859 from related parties, respectively) | |||||
| Costs and operating expenses: | |||||
| Costs of revenue, excluding depreciation and amortization of intangible assets | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Depreciation and amortization expense | |||||
| Goodwill impairment | |||||
| Total costs and operating expenses | |||||
| Loss from operations | |||||
| Interest income and other income (expense), net | |||||
| Loss before benefit (expense) from income taxes and loss from equity method investment | |||||
| Gain on divestiture | |||||
| Loss before expense from income taxes and loss from equity method investment | |||||
| Expense from income taxes | |||||
| Loss from equity method investment | |||||
| Net loss | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation | |||||
| Comprehensive loss | |||||
| Less: Comprehensive income (loss) attributable to non-controlling interest | |||||
| Comprehensive loss attributable to American Well Corporation | |||||
| Net income (loss) attributable to non-controlling interest | |||||
| Net loss attributable to American Well Corporation | |||||
| Net loss per share attributable to common stockholders, basic | |||||
| Net loss per share attributable to common stockholders, diluted | |||||
| Weighted-average common shares outstanding, basic | |||||
| Weighted-average common shares outstanding, diluted | |||||
Loading...